Therapeutic inertia/challenges in up-titration of anti-hypertensive management in older adults addressed by JaredSpitzMD Eugene Yang Roger Blumenthal Garima Sharma M.D in Clin Geriatr Med Framework to improve messaging proposed bit.ly/3UZA1dD

🔥 Our methods paper on AHA Science GoRedforWomen funded study on #SDOH phenotyping of participants of reproductive age at risk of #HTN in AHJ led by Faith Elise Metlock Yvonne Commodore-Mensah, PhD, MHS, RN Khurram Nasir Roger Blumenthal Pamela S Douglas Dr. Laxmi Mehta sciencedirect.com/science/articl…

Don’t miss American Heart Association Cardiogenic Shock Virtual Grands, Tuesday June 11, 12 -1 pm Keynote Speaker: Inova Schar Heart and Vascular Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA REGISTER HERE: heart.zoom.us/meeting/regist… Christopher O'Connor Behnam N. Tehrani, MD Alex Truesdell

Looking forward to September 6-7 Inova Schar Heart and Vascular 2024 Cardiovascular Symposium. All-star Faculty presenting Latest Research Results and Best Practices Brett Atwater Wayne Batchelor, MD Christopher O'Connor For more information and to register go to inovacvsymposium.com

Very proud that rising #Epeeps superstar Eunice Yang is leading enrollment for the #Volt #PFA trial Inova Schar Heart and Vascular ! Congratulations to the entire team on a strong start! Abbott

Wishing our Graduating Cardiology Fellows every success in the next phase in their career. Dr. Andrei Minciunescu: Tufts Advanced Imaging Fellowship Dr. Moemen Eltelbany: Cornell Interventional Cardiology Fellowship Dr. Rafael Arias: Inova Noninvasive Cardiologist

The Inova Schar Heart and Vascular team, led by Wayne Batchelor, MD, Behnam N. Tehrani, MD, performed the first drug coated balloon coronary angioplasty in Northern VA. Excited to bring this treatment option to our patients with in-stent restenosis! Christopher O'Connor

Dual chamber leadless pacemaker implantation is now available for our patients at Inova Schar Heart and Vascular, thanks to Brett Atwater Zachary Hollis, MD and team! Christopher O'Connor

And so we begin first year cardiology fellows bootcamp! Now learning about cath labs with the legend Matthew Sherwood, MD, MHS #thefutureisbright

Thrilled to announce that Inova Schar Heart and Vascular has received the Mitral Foundation Mitral Valve Repair Reference Center Award for the 4th year in a row, in recognition of superior outcomes. Christopher O'Connor

Sun, surf, sea turtles, canyons, and huge, lush green cliffs diving into the ocean. Kauai has it all. The start of some much needed down time with family.

At #CRFInterventionalComplications. August 2-3 in Seattle, Alex Truesdell will join other experts to share knowledge on ”how to fix it” Christopher O'Connor complications2024.crfconferences.com

Performing live cases at the UW Community CTO event following #CRFInterventionalComplications was an excellent opportunity for Lindsey Cilia to showcase her outstanding skills and teach others Christopher O'Connor complications2024.crfconferences.com

Despite benefits in morbidity/mortality, utilization of GDMT remains low. A Minciunescu, Tariq Haddad, et all describe unique QI initiative to increase ARNI and MRA utilization in patients with HFrEF #JACCHF JACC Journals Christopher O'Connor jacc.org/doi/abs/10.101…

.Inova Schar Heart and Vascular approach to management of ICI Myocarditis by international leader in the field Ana Barac, MD, PhD, FACC, FAHA and @chrisDeFilipi #JACCCardioonc JACC Journals InovaCVfellows Inova Schar Cancer Institute

Multistate model to predict risk of adverse events in patients with LVADs described by Palak Shah, et al in #JACCHF Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA, Mitchell Psotka, Shashank Desai Christopher O'Connor jacc.org/doi/10.1016/j.…

Lp(a)-reducing therapeutics show promise to reduce CVD risk. In #JACC editorial, JaredSpitzMD Anandita Agarwala Kulkarni, MD FACC discuss O’Donoghue, M, et al study of off treatment effects of Olpasiran on Lp(a) jacc.org/doi/10.1016/j.… jacc.org/doi/10.1016/j.…

Registration Deadline August 30! Don’t miss -- All-star Faculty presenting Latest Research Results and Best Practices September 6-7 Inova Schar Heart and Vascular 2024 Cardiovascular Symposium. Brett Atwater Wayne Batchelor, MD Christopher O'Connor inovacvsymposium.com

In the wake of the highly successful European Society of Cardiology #ESC2024 that saw the publication of many important RCTs, it bears mentioning that observational data are good for describing practice patterns, not for treatment comparisons.